A Chinese medical products manufacturer with operations in the United States is making an acquisition to try a hand at growing a niche B2B marketplace business.
AnPac Bio-Medical Science Co. makes early cancer screening and detection tools. It plans to operate a business-to-business ecommerce food platform focused on the sale of Asian-sourced food products.
To accomplish that objective, AnPac Bio-Medical Science is spending $2 million in a cash and stock deal to acquire Fresh2 Ecommerce Inc., a B2B ecommerce platform focused on connecting Asian food suppliers and supermarkets in the U.S.
Fresh2 Ecommerce provides an online direct selling platform for food suppliers such as:
- Food companies
- Wholesalers to supermarkets
Fresh2 Ecommerce is also expected to help supermarket operators to identify the source of products. That would enable them to select their food suppliers more efficiently. In addition, AnPac Bio-Medical Science says it from food sources to last-mile delivery.
“The acquisition of Fresh2 Ecommerce is an integral part of our business strategy to serve both restaurant owners and supermarket operators,” says AnPac co-CEO Haohan Xu. “Looking forward, we are commintends to develop smart warehousing and distribution centers that will allow Fresh2 Ecommerce to provide one-stop fulfillment servicesitted to building a B2B ecommerce platform and food supply chain network for Asian food products in the U.S., connecting food suppliers and commercial customers and creating an internet ecosystem for the Asian food industry.”
AnPac Bio-Medical performs a suite of cancer screening and detection tests. They include CDA (Cancer Differentiation Analysis), bio-chemical, immunological, and genomics tests.